about
The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-AnalysisPrognostics factors for mortality and renal recovery in critically ill patients with acute kidney injury and renal replacement therapyDedication increases productivity: an analysis of the implementation of a dedicated medical team in the emergency department.Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.Drivers and Impact of Antifungal Therapy in Critically Ill Patients with Aspergillus-Positive Respiratory Tract Cultures.Delirium recognition by family: European Portuguese validation study of the family confusion assessment method.Intubation-associated pneumonia: An integrative review.PaO2/FiO2 Deterioration During Stable Extracorporeal Membrane Oxygenation Associates With Protracted Recovery and Increased Mortality in Severe Acute Respiratory Distress Syndrome.Delirium in elderly patients: association with educational attainment.Kidney-brain link in traumatic brain injury patients? A preliminary report.Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?Severe community-acquired pneumonia: risk factors for in-hospital mortality.Outcome of severe community-acquired pneumonia: the impact of comorbidities.Aspergillus and other respiratory fungal infections in the ICU: diagnosis and management.Focus on severe infections.When antibiotic treatment fails.Optimal Cerebral Perfusion Pressure Management at Bedside: A Single-Center Pilot Study.Plateau Waves of Intracranial Pressure and Multimodal Brain Monitoring.Adjuvant therapies in critical care: steroids to treat infectious diseases.Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time?Response to Letter to the Editor: 'Comments on procalcitonin for the early diagnosis of sepsis in burn patients: A retrospective study'.
P50
Q36231431-045CCD18-79BE-49E9-A8EC-345238B1E241Q36788198-EACF9684-4314-4A4F-AC3F-C89AC69937C5Q37656836-F06CCA98-C525-4CD5-BFF9-F85CF5357FE1Q38384662-BC1A16E6-4691-4436-88CD-C2839A4184D1Q38697723-A2078ED4-E040-44E4-B5D9-6946AA761D21Q39157533-77E276BF-22B4-4FEE-B453-4F5521D3FD8DQ40068236-E5CE29AB-EDF1-4F51-96D7-B58ED76CBEDAQ40552432-494A10C1-5298-49A7-8ADE-CA1FE1E562BDQ40630554-681D893A-1CC5-4BBB-97ED-20C2BE6A9A31Q44347365-91AA42D8-D0D9-47A0-BD21-CCD25453B1B6Q45007561-CA5A8B8A-5D2F-444B-9A40-EB185CB9FFDDQ45929977-EBF1DE5F-4AAA-4B7C-947D-3DDEAD025355Q46692032-45063D95-E0E8-4787-B4D4-354930912C9AQ47659763-E3FF0AE7-73F9-4AD5-83BB-6FC93AF7F57BQ48148163-201625F1-7C17-49F5-8D2B-268F57F4CCC6Q48185895-37AECB3A-C923-4396-91EF-6722EA8D4415Q48387529-016FEE5F-28CB-44CC-86DB-EFA18D8A3A23Q48745840-165A6CB3-67B3-45DD-B040-F0D793F43EACQ49914898-31704C78-9C62-4878-8DC3-4A421B709C7EQ50101377-5347BDE7-60A3-4C31-A2DE-91A349252A29Q50208951-48ED5779-156D-4A2F-8D38-1568C193D290
P50
description
researcher (ORCID 0000-0003-4323-0220)
@en
wetenschapper
@nl
name
JA Paiva
@en
JA Paiva
@nl
type
label
JA Paiva
@en
JA Paiva
@nl
prefLabel
JA Paiva
@en
JA Paiva
@nl
P31
P496
0000-0003-4323-0220